Global Medical REIT Announces Succession Plan; CEO Transition Expected In 2025; Jeffrey Busch To Remain On Board Of Directors As Non-Executive Chairman; Lori Wittman Appointed Lead Independent Director Effective January 1, 2025
Global Medical REIT Announces Succession Plan; CEO Transition Expected In 2025; Jeffrey Busch To Remain On Board Of Directors As Non-Executive Chairman; Lori Wittman Appointed Lead Independent Director Effective January 1, 2025
Chief Executive Officer Transition Expected in 2025
首席執行官更替預計在2025年進行
Mr. Busch to Remain on Board of Directors as Non-Executive Chairman
布希先生將繼續擔任董事會非執行主席
Lori Wittman Appointed Lead Independent Director Effective January 1, 2025
洛蕾·維特曼被任命爲獨立首席董事,自2025年1月1日起生效
Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), a net-lease medical real estate investment trust (REIT) that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems, today announced that as part of the Company's succession planning efforts, the Board of Directors (the "Board") has reached an agreement with Mr. Jeffrey Busch, Chairman of the Board of Directors and Chief Executive Officer ("CEO") of the Company, regarding Mr. Busch's transition from service as CEO and with anticipated continuation as a member of the Board.
Global Medical REIT (紐交所:GMRE)(以下簡稱"公司"或"GMRE")是一家淨租賃醫療股權房地產投資信託(REITs),專注於收購醫療設施並將這些設施租賃給醫療團隊及區域型和National HealthCare系統。今天,公司宣佈,作爲公司繼任計劃的一部分,董事會("董事會")已與董事會主席及首席執行官("CEO")傑弗裏·布希先生達成一致,涉及布希先生由CEO轉變的相關事宜,並預計他將繼續作爲董事會成員。
Pursuant to the agreement with Mr. Busch, his service as CEO will end on the first to occur of (i) the date that a successor CEO has been appointed by the Board pursuant to the Company's CEO succession plan or (ii) June 30, 2025 (such date that is first to occur, the "Succession Date").
根據與布希先生的協議,他作爲CEO的服務將於以下兩者中較早發生的日期結束:(i) 根據公司的CEO繼任計劃,董事會任命繼任CEO的日期,或(ii) 2025年6月30日(此日期較早發生的,稱爲「繼任日期」)。